Cidara Therapeutics (CDTX:NAS) and scPharmaceuticals (SCPH:NAS) Trading at Less than Cash Value

Stockcalc – Free Trial

Have a free look inside the StockCalc website at www.stockcalc.com



I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com/TopPicks.aspx.

Trading at Less than Cash Value

Today we are looking at companies trading at less than cash value meaning companies whose current share price is less than the cash per share on the balance sheet. We also show the value of cash net debt per share to show how much cash per share would be left if the debt was paid off.

What this Means…

Companies can have more cash per share than the actual share price for a number of reasons including they just raised capital, are in industries that experience high burn rates and will eat through the cash quickly or if there is a lot of uncertainty about the future of the company. Companies earning a positive net income will have a P/E greater than 0 and are worth exploring in more detail.

Today’s Data on NASDAQ

Today’s data is for companies listed on the NASDAQ.

Symbol Name Close Price Shares Outstanding P/E P/B Cash per Share Net Cash per Share
LEXEA Liberty Expedia Holdings Inc 42.300000 57315762 None 0.9932 52.55 -22.37
LEXEB Liberty Expedia Holdings Inc 40.170000 57315762 None 0.9432 52.55 -22.37
SOHU Sohu.com Ltd 21.460000 38916788 None 1.2571 29.71 23.98
LJPC La Jolla Pharmaceutical Co 6.180000 26233631 None 2.3719 7.79 0.16
CAAS China Automotive Systems Inc 2.810000 31644004 None 0.3083 3.03 0.78
CDTX Cidara Therapeutics Inc 2.840000 27751431 None 1.1270 3.02 2.66
SCPH scPharmaceuticals Inc 4.180000 18569289 None 0.9308 5.13 4.61
IDRA Idera Pharmaceuticals Inc 2.570000 27181436 None 0.9331 3.03 3.95
ETTX Entasis Therapeutics Holdings Inc 4.900000 13099735 None 0.7094 7.18 None
SNNA Sienna Biopharmaceuticals Inc 2.830000 21140101 2.2095 1.3315 3.03 1.61
AQXP Aquinox Pharmaceuticals Inc 2.390000 23537368 None 0.7332 3.68 3.68
VVUS VIVUS Inc 4.930000 10629923 None None 5.46 -22.78
ARAV Aravive Inc 4.200000 11182025 4.0777 0.7371 5.60 5.41
ASNS Arsanis Inc 2.730000 14315410 None 1.4009 2.85 2.10
GIGM GigaMedia Ltd 2.790000 11052235 None 0.5280 5.42 5.77
TRMT Tremont Mortgage Trust 8.680000 3179118 None 0.4845 9.47 -0.43
BIQI Renmin Tianli Group Inc 2.810000 8033745 19.5000 0.2583 7.64 7.39
GEVO Gevo Inc 2.540000 8640433 None 0.2354 4.43 2.95
ONTX Onconova Therapeutics Inc 3.360000 5674220 None 1.7556 3.94 None
SAEX SAExploration Holdings Inc 4.120000 2917160 None 0.3679 6.97 -25.35
RLM Realm Therapeutics PLC 2.580000 4662476 None 0.4954 3.48 2.74
MDGS Medigus Ltd 2.640000 3796602 None 1.1324 3.14 None
KBSF KBS Fashion Group Ltd 3.710000 2228497 None 0.1205 9.07 8.58
DFFN Diffusion Pharmaceuticals Inc 2.250000 3376245 1.0484 0.3633 3.26 4.64
CHFS CHF Solutions Inc 7.470000 512460 None 0.3966 16.04 2.58

Let’s look at a few companies…

Lets look at a couple of the companies on this list to get a better understanding of them.

CDTX:NAS Cidara Therapeutics

http://www.cidara.com
Cidara Therapeutics has 61 employees and is headquartered in United States.
Cidara Therapeutics Inc mainly develops anti-infective drugs in the United States. It attends to serious fungal infections through its drug candidates and proprietary immunotherapy technology platform, Cloudbreak.

SCPH:NAS scPharmaceuticals

http://www.scpharmaceuticals.com
scPharmaceuticals has 27 employees and is headquartered in United States.
scPharmaceuticals Inc is a pharmaceutical company. Its pipeline includes products in various stages of clinical and non-clinical development. It focuses on proven pharmaceutical products in the cardiovascular and infectious disease therapeutic areas.

Free Valuation

Run a valuation on any of the companies listed above at www.stockcalc.com/valureport.aspx or subscribe at our Stockcalc Facebook Page to receive this list each day Stockcalc Reports.

The content presented here is in part from the website stockcalc.com and is provided on an as is or as available basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.